The latest POWR Ratings are in. This is your opportunity to review the stocks that have moved up to Buy and Strong Buy and those that have fallen to Sell and Strong Sell ratings. The POWR Ratings are updated on a daily basis, providing fresh ratings to help traders maximize the return on their investments.

All in all, about ten total stocks have just been downgraded to Strong Sells. This means these stocks should be avoided until they are rated a Buy or Strong Buy. 

Let’s take a look at three of the stocks that were recently downgraded to F ratings, indicating they are Strong Sells: Integrated Media Technology (IMTE - Get Rating), Orgenesis (ORGS - Get Rating), and Greenlane Holdings (GNLN - Get Rating).

Integrated Media Technology (IMTE - Get Rating)

IMTE has an overall grade of F, which translates into a Strong Sell rating in the POWR Ratings system. The stock has grades of F in the Quality, Value, and Stability components. Investors who would like to learn more about how IMTE grades out in the Momentum, Sentiment, and Growth components can do so by clicking here.

Of the 44 stocks in the Technology – Electronics industry, IMTE is ranked 42nd. To find top stocks in this industry, click here. IMTE has returned 20% so far this year. 

Though IMTE’s niche of developing and commercializing visual technology with three-dimensional technology certainly has potential, it is clear this company has a ways to go before it can be considered a wise investment.

Orgenesis (ORGS - Get Rating)

ORGS has an overall grade of F or a Strong Sell rating in our POWR Ratings system. The stock has grades of D in the Quality, Value, and Growth components. Click here to learn more about how ORGS fares in the Momentum, Sentiment, and Stability components.

Of the 234 publicly traded companies in the Medical – Pharmaceuticals industry, ORGS is ranked 223. As a whole, the Medical – Pharmaceuticals industry is F-rated. However, there are some Buy-rated stocks in this industry, which you can find by clicking here.

ORGS has been sliding since mid-March. The stock is currently trading about 90 cents above its 52-week low of $4.30. The stock’s 52-week high is $8.30.

Greenlane Holdings (GNLN - Get Rating)

GNLN is a distributor of products used for vaporizing cannabis and other materials. GNLN’s customers range from cannabis shops to regional retailers, cannabis cultivators, dispensaries, and cannabis processors. GNLN also has e-commerce sites that sell vaporizing products directly to consumers.

GNLN has an overall grade of F or a Strong Sell rating in the POWR Ratings system with a grade of F in the Quality component and grades of D in the Sentiment and Stability components. Investors who are curious as to how GNLN fares in the Momentum, Value, and Growth components can find out by clicking here.

Of the 11 publicly traded companies in the Tobacco industry, GNLN is ranked dead last. You can find top-ranked stocks in this industry by clicking here.

GNLN’s future doesn’t look that bright as the sale of vaporizers, and related products have fallen off a cliff. Even those who are passionate about cannabis are questioning whether using such devices for cannabis consumption is wise due to potential health risks. Savvy investors should steer clear of GNLN in the meantime.

IMTE shares were trading at $4.61 per share on Tuesday morning, down $0.07 (-1.50%). Year-to-date, IMTE has gained 18.21%, versus a 11.23% rise in the benchmark S&P 500 index during the same period.

About the Author: Patrick Ryan

Patrick Ryan has more than a dozen years of investing experience with a focus on information technology, consumer and entertainment sectors. In addition to working for StockNews, Patrick has also written for Wealth Authority and Fallon Wealth Management. More...

More Resources for the Stocks in this Article